B

Blade Air Mobility Inc
NASDAQ:BLDE

Watchlist Manager
Blade Air Mobility Inc
NASDAQ:BLDE
Watchlist
Price: 5.09 USD 0.79% Market Closed
Market Cap: $412.4m

Blade Air Mobility Inc
Investor Relations

Blade Air Mobility, Inc. is a technology-powered global air mobility platform. The company is headquartered in New York City, New York. The company went IPO on 2019-09-17. The firm provides consumers with an alternative to ground transportation for congested routes, within the Northeast United States and India, through its helicopter, amphibious seaplane and fixed-wing transportation services. Its network of operator partners provides aircraft, pilots, maintenance, insurance and fuel, while it focuses on booking and fliers through its mobile application, Website and Flier Relations team and providing air transportation alternatives to some of the congested ground routes in the United States and India. Its customer-to-cockpit technology stack enables it to manage hundreds of fliers across flights, coordinating multiple operators flying between terminals across its route network. Its asset-light model with its passenger terminal infrastructure is designed to provide transition to Electric Vertical Aircraft (EVA) enabling lower-cost air mobility.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Aug 5, 2025
AI Summary
Q2 2025

Major Divestiture: Blade announced the sale of its Passenger business to Joby Aviation for up to $125 million, marking a strategic shift to focus exclusively on the Medical segment.

New Pure-Play Medical: The company will be renamed Strata Critical Medical and become a stand-alone, pure-play contractual medical business, targeting organic growth and M&A.

Strong Medical Growth: Medical revenue accelerated to 18% growth in Q2 2025, with record revenues driven by new customer wins and expanded product lines.

Financial Impact: The divestiture is expected to be EBITDA and free cash flow neutral annually, supported by $7 million in corporate cost efficiencies.

Outlook Reaffirmed: Management reaffirmed 2025 full company guidance (excluding the divestiture), projecting $245–265 million in revenue and double-digit EBITDA margin.

Capital Deployment: The company will have about $200 million in cash after the transaction to fund organic growth and acquisitions, with up to $35 million additional earnout possible.

Joby Partnership: Strata will partner with Joby for access to eVTOL aircraft for medical use, expected to provide cost and operational benefits.

Leadership Transition: Rob Wiesenthal will join Joby as CEO of Blade Air Mobility and serve as Chairman of Strata; existing executives will lead Strata as Co-CEOs.

Key Financials
Medical Revenue
$45.1 million
Medical Segment Adjusted EBITDA Margin
13.4%
Passenger Segment Flight Margin
30.5%
Passenger Segment Adjusted EBITDA
$2.4 million
Adjusted EBITDA
$3.2 million
Cash and Short-Term Investments
$113.4 million
Days Sales Outstanding
32 days
Capital Expenditures
$2.7 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Robert S. Wiesenthal
CEO & Director
No Bio Available
Ms. Melissa M. Tomkiel J.D.
President, General Counsel & Corporate Secretary
No Bio Available
Mr. William A. Heyburn
CFO & Head of Corporate Development
No Bio Available
Mr. Amir M. Cohen
Chief Accounting Officer
No Bio Available
Mr. Seth J. Bacon
Chief Executive Officer of Trinity Air Medical, LLC
No Bio Available

Contacts

Address
NEW YORK
New York City
499 East 34Th Street, Suite 800
Contacts
+12129671009.0
ir.blade.com